Click here to get full coverage on $RCKT stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

$RCKT stock is up 13% today. Here's what we see in our data.  Quiver Quantitative

$RCKT stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri - GuruFocus

Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri  GuruFocus

Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri - GuruFocus

Click here to get full coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell? - MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell?  MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell? - MarketBeat

Click here to get full coverage on Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery - Yahoo Finance

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery  Yahoo Finance

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald - TradingView

Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald  TradingView

Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald - TradingView

Click here to get full coverage on RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus - Nasdaq

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus  Nasdaq

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus - Nasdaq

Click here to get full coverage on Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ) - Seeking Alpha

Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ)  Seeking Alpha

Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ) - Seeking Alpha

Click here to get full coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen - MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen  MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen - MarketBeat

Click here to get full coverage on RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy  Yahoo Finance

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance

Click here to get full coverage on RCKT: Focused on rare cardiac gene therapies, advancing pivotal trials, and exploring partnerships - TradingView

RCKT: Focused on rare cardiac gene therapies, advancing pivotal trials, and exploring partnerships  TradingView

RCKT: Focused on rare cardiac gene therapies, advancing pivotal trials, and exploring partnerships - TradingView

Click here to get full coverage on Insider Sale: CEO of $RCKT Sells 5,990 Shares - Quiver Quantitative

Insider Sale: CEO of $RCKT Sells 5,990 Shares  Quiver Quantitative

Insider Sale: CEO of $RCKT Sells 5,990 Shares - Quiver Quantitative

Click here to get full coverage on Brokers Set Expectations for RCKT FY2026 Earnings - MarketBeat

Brokers Set Expectations for RCKT FY2026 Earnings  MarketBeat

Brokers Set Expectations for RCKT FY2026 Earnings - MarketBeat

Click here to get full coverage on Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now?  Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - Yahoo Finance

Click here to get full coverage on Jefferies Raises PT on Rocket Pharmaceuticals, Inc. (RCKT) to $3.00; Maintains ‘Hold’ Rating - Yahoo Finance

Jefferies Raises PT on Rocket Pharmaceuticals, Inc. (RCKT) to $3.00; Maintains ‘Hold’ Rating  Yahoo Finance

Jefferies Raises PT on Rocket Pharmaceuticals, Inc. (RCKT) to $3.00; Maintains ‘Hold’ Rating - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring A 71% Upside Potential - DirectorsTalk Interviews

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring A 71% Upside Potential  DirectorsTalk Interviews

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring A 71% Upside Potential - DirectorsTalk Interviews

Click here to get full coverage on Cantor Fitzgerald Raises Rocket Pharmaceuticals (RCKT) Price Tar - GuruFocus

Cantor Fitzgerald Raises Rocket Pharmaceuticals (RCKT) Price Tar  GuruFocus

Cantor Fitzgerald Raises Rocket Pharmaceuticals (RCKT) Price Tar - GuruFocus

Click here to get full coverage on Rocket Pharmaceuticals Stock (RCKT) Opinions on FDA Clinical Hold Lift - Quiver Quantitative

Rocket Pharmaceuticals Stock (RCKT) Opinions on FDA Clinical Hold Lift  Quiver Quantitative

Rocket Pharmaceuticals Stock (RCKT) Opinions on FDA Clinical Hold Lift - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $RCKT Given $263.0 Price Target | RCKT Stock News - Quiver Quantitative

New Analyst Forecast: $RCKT Given $263.0 Price Target | RCKT Stock News  Quiver Quantitative

New Analyst Forecast: $RCKT Given $263.0 Price Target | RCKT Stock News - Quiver Quantitative

Click here to get full coverage on Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ - GuruFocus

Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ  GuruFocus

Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ - GuruFocus

Click here to get full coverage on Rocket Pharmaceuticals Launches New $100M At-The-Market Program - TipRanks

Rocket Pharmaceuticals Launches New $100M At-The-Market Program  TipRanks

Rocket Pharmaceuticals Launches New $100M At-The-Market Program - TipRanks

Click here to get full coverage on Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock - simplywall.st

Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock  simplywall.st

Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock - simplywall.st

Click here to get full coverage on Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation - Yahoo Finance

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation  Yahoo Finance

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy - MarketBeat

Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy  MarketBeat

Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy - MarketBeat

Click here to get full coverage on Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress - Business Wire

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress  Business Wire

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress - Business Wire

Click here to get full coverage on Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by Monaco Asset Management SAM - MarketBeat

Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by Monaco Asset Management SAM  MarketBeat

Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by Monaco Asset Management SAM - MarketBeat

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) files $400M mixed shelf - StreetInsider

Rocket Pharmaceuticals (RCKT) files $400M mixed shelf  StreetInsider

Rocket Pharmaceuticals (RCKT) files $400M mixed shelf - StreetInsider

Click here to get full coverage on Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume - CNBC

Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume  CNBC

Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume - CNBC

Click here to get full coverage on $RCKT stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

$RCKT stock is up 15% today. Here's what we see in our data.  Quiver Quantitative

$RCKT stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study - Yahoo Finance

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study  Yahoo Finance

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study - Yahoo Finance

Click here to get full coverage on $RCKT stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

$RCKT stock is up 10% today. Here's what we see in our data.  Quiver Quantitative

$RCKT stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program  Seeking Alpha

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha

Click here to get full coverage on Balanced View on RCKT: Clinical Progress Offsetting Execution and Regulatory Risks Supports Hold Rating - TipRanks

Balanced View on RCKT: Clinical Progress Offsetting Execution and Regulatory Risks Supports Hold Rating  TipRanks

Balanced View on RCKT: Clinical Progress Offsetting Execution and Regulatory Risks Supports Hold Rating - TipRanks

Click here to get full coverage on Rocket Pharma stock cut at J.P. Morgan (RCKT:NASDAQ) - Seeking Alpha

Rocket Pharma stock cut at J.P. Morgan (RCKT:NASDAQ)  Seeking Alpha

Rocket Pharma stock cut at J.P. Morgan (RCKT:NASDAQ) - Seeking Alpha

Click here to get full coverage on Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now? - Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now?  Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Martin Wilson Sells 12,253 Shares - MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Martin Wilson Sells 12,253 Shares  MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Martin Wilson Sells 12,253 Shares - MarketBeat

Click here to get full coverage on Rocket Pharmaceuticals: Q4 Earnings Snapshot - theheraldreview.com

Rocket Pharmaceuticals: Q4 Earnings Snapshot  theheraldreview.com

Rocket Pharmaceuticals: Q4 Earnings Snapshot - theheraldreview.com

Click here to get full coverage on Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences  Business Wire

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

Click here to get full coverage on Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference  Business Wire

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire

Click here to get full coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) CEO Sells $40,643.49 in Stock - MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) CEO Sells $40,643.49 in Stock  MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) CEO Sells $40,643.49 in Stock - MarketBeat

Click here to get full coverage on The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock - MarketBeat

The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock  MarketBeat

The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock - MarketBeat

Click here to get full coverage on Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress  Business Wire

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire

Click here to get full coverage on Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?  Yahoo Finance

Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Click here to get full coverage on RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure - Yahoo Finance

RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure  Yahoo Finance

RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Downgraded to Underweight by JP Mo - GuruFocus

Rocket Pharmaceuticals (RCKT) Downgraded to Underweight by JP Mo  GuruFocus

Rocket Pharmaceuticals (RCKT) Downgraded to Underweight by JP Mo - GuruFocus

Click here to get full coverage on Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - simplywall.st

Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders  simplywall.st

Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - simplywall.st

Click here to get full coverage on Rocket Pharmaceuticals enters $100 million at-the-market offering agreement - Investing.com Australia

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement  Investing.com Australia

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement - Investing.com Australia

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Insider Monkey

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position  Insider Monkey

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Insider Monkey

Click here to get full coverage on Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow - Yahoo Finance

Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow  Yahoo Finance

Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - Yahoo Finance

Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death  Yahoo Finance

Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - Yahoo Finance

Click here to get full coverage on Wednesday 1/7 Insider Buying Report: CASY, RCKT - Nasdaq

Wednesday 1/7 Insider Buying Report: CASY, RCKT  Nasdaq

Wednesday 1/7 Insider Buying Report: CASY, RCKT - Nasdaq

Click here to get full coverage on Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain (RCKT) - Seeking Alpha

Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain (RCKT)  Seeking Alpha

Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain (RCKT) - Seeking Alpha

Click here to get full coverage on Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026 - Seeking Alpha

Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026  Seeking Alpha

Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026 - Seeking Alpha

Click here to get full coverage on KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2026-CES2 (RCKT 2026-CES2) - The AI Journal

KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2026-CES2 (RCKT 2026-CES2)  The AI Journal

KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2026-CES2 (RCKT 2026-CES2) - The AI Journal

Click here to get full coverage on Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals? - RTTNews

Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals?  RTTNews

Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals? - RTTNews

Click here to get full coverage on Rocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAE (NASDAQ:RCKT) - Seeking Alpha

Rocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAE (NASDAQ:RCKT)  Seeking Alpha

Rocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAE (NASDAQ:RCKT) - Seeking Alpha

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Resubmitted Gene Therapy Applicati - GuruFocus

Rocket Pharmaceuticals (RCKT) Resubmitted Gene Therapy Applicati  GuruFocus

Rocket Pharmaceuticals (RCKT) Resubmitted Gene Therapy Applicati - GuruFocus

Click here to get full coverage on FDA Greenlights Revolutionary Gene Therapy: New Hope for Fatal Heart Condition Patients - Stock Titan

FDA Greenlights Revolutionary Gene Therapy: New Hope for Fatal Heart Condition Patients  Stock Titan

FDA Greenlights Revolutionary Gene Therapy: New Hope for Fatal Heart Condition Patients - Stock Titan

Click here to get full coverage on Rocket Pharma stock falls on FDA clinical hold (RCKT:NASDAQ) - Seeking Alpha

Rocket Pharma stock falls on FDA clinical hold (RCKT:NASDAQ)  Seeking Alpha

Rocket Pharma stock falls on FDA clinical hold (RCKT:NASDAQ) - Seeking Alpha

Click here to get full coverage on Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025 - Contact Levi & Korsinsky - TMX Newsfile

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025 - Contact Levi & Korsinsky  TMX Newsfile

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025 - Contact Levi & Korsinsky - TMX Newsfile

Click here to get full coverage on Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)  Business Wire

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire

Click here to get full coverage on Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple - Yahoo Finance

Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple  Yahoo Finance

Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple - Yahoo Finance

Click here to get full coverage on Rocket Pharma’s SWOT analysis: gene therapy stock faces pivotal moment - Investing.com

Rocket Pharma’s SWOT analysis: gene therapy stock faces pivotal moment  Investing.com

Rocket Pharma’s SWOT analysis: gene therapy stock faces pivotal moment - Investing.com

Click here to get full coverage on Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Fitch Assigns Expected Ratings to RCKT Mortgage Trust 2025-CES11 - TradingView

Fitch Assigns Expected Ratings to RCKT Mortgage Trust 2025-CES11  TradingView

Fitch Assigns Expected Ratings to RCKT Mortgage Trust 2025-CES11 - TradingView

Click here to get full coverage on RCKT Stock Price, News & Analysis | Rocket Pharmaceu - Stock Titan

RCKT Stock Price, News & Analysis | Rocket Pharmaceu  Stock Titan

RCKT Stock Price, News & Analysis | Rocket Pharmaceu - Stock Titan

Click here to get full coverage on Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class - GlobeNewswire

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class  GlobeNewswire

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class - GlobeNewswire

Click here to get full coverage on Why Rocket Pharma Is Rising In Pre-market? - Nasdaq

Why Rocket Pharma Is Rising In Pre-market?  Nasdaq

RCKT

Price Chart

Key Statistics

Technicals

About RCKT

Latest News

$RCKT stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri - GuruFocus

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell? - MarketBeat

Advanced Charts

Top Gainers

Top Losers